WTO TRIPS Council (October 2019): Statement of South Africa on the Transparency of R&D Costs and Pricing of Medicines and Health Technology

On Friday, 18 October 2019, South Africa delivered the following statement at the WTO TRIPS Council on transparency of R&D Costs and Pricing of Medicines and Health Technology. Intellectual Property and the Public Interest: R&D Costs and Pricing of Medicines… Continue Reading

NGO letter to WIPO negotiators, regarding proposal to sidetrack WIPO work on copyright limitations and exceptions

NGO-letter-on-proposed-LnE-agenda-change-SCCR39-10.21 Chair-proposal-NEXT STEPS 10-21-19 October 21, 2019 RE: Chair Proposal on Next Steps for Agenda Items 5 and 6 Dear Delegates at WIPO SCCR 39: We are shocked by the attached proposal of the Chair to change the title of… Continue Reading

KEI Comments to the NIH on Exclusive License to Opsis Therapeutics for Retinal Cell Therapies

On October 18, 2019, Knowledge Ecology International (KEI) submitted comments to the Federal Register Notice for the “Prospective Grant of an Exclusive Patent License: Compositions, Devices and Processes for Production and Delivery of Cell Grafts of Manufactured Retinal Pigment Epithelium… Continue Reading

KEI and UACT Comments to NIH on License to T-Cell Therapy for Cancer to Ziopharm Oncology

(Update: The NIH provided a response to our comments on November 15, 2019) On Friday October 18, 2019, Knowledge Ecology International and the Union for Affordable Cancer Treatment (UACT) submitted comments on the “Prospective Grant of an Exclusive Patent License:… Continue Reading